Aspirin may be considered for primary prevention in selected patients with diabetes mellitus (DM). Lipoprotein(a) [Lp(a)] is an independent cardiovascular risk factor linked to myocardial infarction and stroke and may promote thrombogenicity. Whether the association between aspirin use and cardiovascular outcomes...
M. Rossi, E. Tartaglia, A. Askarinejad et al.· European Heart Journal· 0 citations
Atrial fibrillation (AF) in younger adults is a highly heterogeneous condition, encompassing a broad clinical spectrum and associated with markedly different cardiovascular outcomes.
We aimed to identify distinct clinical–echocardiographic phenotypes of AF in patients aged <65 years and to evaluate their a...
A. Rigutini, T. Bucci, E. Tartaglia et al.· European Heart Journal· 0 citations
Pulmonary vein isolation (PVI) is a well-established procedure for treating atrial fibrillation (AF); however, early recurrence of atrial tachyarrhythmias (ERAT) is common. Electrical cardioversion (ECV) is one treatment for ERAT, but optimal timing is unestablished.
To evaluate the association between the...
L. Serio, A. Askarinejad, T. Bucci et al.· European Heart Journal· 0 citations
BACKGROUND AND AIM
Fabry disease (FD) is frequently complicated by renal impairment and cardiovascular events; however, evidence on sodium-glucose cotransporter-2 inhibitors (SGLT2i) in this population is scarce. Accordingly, we assessed the association between SGLT2i exposure and cardiovascular outcomes in adults with...
Leandra Serio, M. Rossi, A. Askarinejad et al.· Diabetes, obesity and metabo...· 0 citations
Three distinct phenotypic clusters were identified, each with heterogeneous clinical characteristics and outcomes, underscoring the need for more individualised, phenotype-informed management strategies in this complex patient population.
A. Askarinejad, T. Bucci, Enrico Tartaglia et al.· European journal of internal...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.